Insights

AI-Driven Transformation Syner-G recently launched 3Di, a people-centered AI transformation service, and partnered with Weave to deliver AI-augmented authoring and knowledge management across the IND-to-NDA lifecycle, signaling strong capabilities in AI-enabled development and regulatory efficiency.

Global Delivery Network With a global delivery team spanning North America, Europe, and APAC, Syner-G can serve as an end-to-end development and delivery partner for multinational programs, enabling seamless cross-border regulatory submissions and lifecycle management.

Quality and Compliance Existing TrackWise usage points to robust quality and regulatory compliance capabilities, presenting opportunities to expand QMS optimization and AI-assisted regulatory preparation across IND-to-NDA programs.

Growth Momentum Recent leadership additions and strategic mergers, including the Sequoia Biotech integration, demonstrate a growth trajectory and expanded capability set, indicating capacity for larger programs and expanded commercial services.

Culture Advantage Recognition as a best place to work highlights strong employee engagement and stability, appealing to clients seeking reliable long-term outsourcing partners for complex, multi-year programs.

Syner-G Tech Stack

Syner-G uses 8 technology products and services including Cloudflare Web Optimizations, Johnson Controls Metasys, Salesforce, and more. Explore Syner-G's tech stack below.

  • Cloudflare Web Optimizations
    Analytics
  • Johnson Controls Metasys
    Control Systems
  • Salesforce
    Customer Relationship Management
  • Shopify
    E-commerce
  • Veeva Systems
    IT Infrastructure & Operations Management
  • Microsoft
    Miscellaneous
  • Piwik PRO Core
    Web Analytics
  • Apache
    Web Servers

Media & News

Syner-G's Email Address Formats

Syner-G uses at least 2 format(s):
Syner-G Email FormatsExamplePercentage
First.Last@synergbiopharma.comJohn.Doe@synergbiopharma.com
96%
First.Middle@synergbiopharma.comJohn.Michael@synergbiopharma.com
4%
First.Last@synergpharma.comJohn.Doe@synergpharma.com
90%
FLast@synergpharma.comJDoe@synergpharma.com
4%
LF@synergpharma.comDJ@synergpharma.com
3%
First.Middle@synergpharma.comJohn.Michael@synergpharma.com
3%

Frequently Asked Questions

What is Syner-G's phone number?

Minus sign iconPlus sign icon
You can contact Syner-G's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Syner-G's official website and social media links?

Minus sign iconPlus sign icon
Syner-G's official website is synergbiopharma.com and has social profiles on LinkedIn.

What is Syner-G's NAICS code?

Minus sign iconPlus sign icon
Syner-G's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Syner-G have currently?

Minus sign iconPlus sign icon
As of July 2026, Syner-G has approximately 345 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Owner: A. K.Country Head - India: T. P. P. D.Associate Vice President Qa: L. H.. Explore Syner-G's employee directory with LeadIQ.

What industry does Syner-G belong to?

Minus sign iconPlus sign icon
Syner-G operates in the Pharmaceutical Manufacturing industry.

What technology does Syner-G use?

Minus sign iconPlus sign icon
Syner-G's tech stack includes Cloudflare Web OptimizationsJohnson Controls MetasysSalesforceShopifyVeeva SystemsMicrosoftPiwik PRO CoreApache.

What is Syner-G's email format?

Minus sign iconPlus sign icon
Syner-G's email format typically follows the pattern of First.Last@synergbiopharma.com. Find more Syner-G email formats with LeadIQ.
Syner-G logo

Syner-G

Pharmaceutical ManufacturingMassachusetts, United States201-500 Employees

Syner-G BioPharma Group serves as a Strategic Development & Delivery Partner to biopharma innovators, offering integrated guidance across scientific, regulatory, technical, and strategic aspects of the development lifecycle. With a global team spanning North America, Europe, and APAC, it collaborates with clients to navigate the complexity of development and commercialization, aiming to reduce risk and accelerate progress. The firm covers IND-to-NDA milestones by combining scientific rigor with operational excellence to advance therapies that improve patient lives.

Headquartered in Framingham, Massachusetts, the company is a mid-sized, globally distributed organization that has grown through a 2024 merger with Sequoia Biotech and a 2023 acquisition of RMC Pharmaceutical Solutions. In June 2026, Syner-G launched 3D Intelligence (3Di), a people-centered AI transformation service for the biopharma development lifecycle.

Section iconCompany Overview

Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
201-500

Section iconFunding & Financials

  • $250M$500M

    Syner-G's revenue is estimated to be in the range of $250M$500M

Section iconFunding & Financials

  • $250M$500M

    Syner-G's revenue is estimated to be in the range of $250M$500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.